NEW YORK, March 1, (GenomeWeb News) - Clinical Data today said it has reorganized its business into three units: PGxHealth, Cogenics, and Vital Diagnostics.
The PGX Health division includes assets from newly acquired Genaissance. The unit is developing CNS, cardiovascular, and oncology tests, the company said.
The Cogenics unit, which represents the combined operations and marketing infrastructure of Genaissance, Lark, and Icoria to provide comprehensive pharmacogenomics and molecular services, is developing GLP-validated and research assays.
Vital Diagnostics, derived from the operations of Clinical Data, Vital, and Electa Labs, is geared toward IVD services for customers in 100 countries.